rss
J Med Ethics 2008;34:838-839 doi:10.1136/jme.2007.022525
  • 10 years of stem cells

Stem cell spinal cord regeneration: first do no harm

  1. M Legge1,
  2. L M Jones2
  1. 1
    Departments of Biochemistry and Pathology, University of Otago, Dunedin, New Zealand
  2. 2
    School of Physical Education, University of Otago, Dunedin, New Zealand
  1. Associate Professor M Legge, Departments of Biochemistry and Pathology, University of Otago, PO BOX 56, Dunedin 9054, New Zealand; mike.legge{at}stonebow.otago.ac.nz
  • Received 29 July 2007
  • Revised 13 January 2008
  • Accepted 4 February 2008

Abstract

The prospect of “curing” spinal cord injury using stem cell therapy is one of the significant goals of many stem cell researchers. In this communication we consider some of the physiological implications of successful in vivo spinal cord repair and the ethical issues this potential revolutionary therapy will raise.

Footnotes

  • Funding: University of Otago Research Award.

  • Competing interests: None.

This Article

  1. Abstract
  2. Full text
  3. PDF

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.